NASDAQ$NUTX

Nutex Health Inc · Q2 2018 earnings

Q2 2018 earnings ·

Headline financials

Total Revenue

$3.73K

No prior period
EPS

-$0.01

No prior period
Free Cash Flow

-$726K

No prior period
Net Income

-$726K

No prior period
Operating Income

-$489K

No prior period
Gross Profit

-$4.17K

No prior period
Cash & Equivalents

$50.9K

No prior period
Total Assets

$2.98M

No prior period

Revenue & EPS history

Nutex Health Inc · Revenue · Quarterly

$3.73K

Q2 2018

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports

Historical avg

+1.9%

Avg return

Earnings day

+17.2%

Avg return

5 days after

+21.1%

Avg return

30 days after

62%

8 / 13 earnings

Positive

+22.4%

Q1 2022

Best reaction

-14.3%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.4%+8.0%+14.4%
Q4 2025-14.3%-14.1%-4.2%
Q3 2025+0.0%+32.9%+64.1%
Q1 2025+1.0%+40.2%+0.2%
Q3 2024+6.3%+38.2%+39.3%
Q2 2024+0.9%+62.7%+173.1%
Q1 2024+6.2%+14.8%+0.7%
Q3 2023+0.0%-6.0%-22.8%
Q2 2023+3.6%+0.9%-20.1%
Q1 2023+8.9%+10.3%-17.8%
Q3 2022-9.2%+1.7%+59.7%
Q2 2022-8.2%-27.9%-53.8%
Q1 2022+22.4%+61.8%+41.2%
Q3 2021
Q2 2021
Q1 2021
Q3 2020
Q1 2020
Q3 2019
Q1 2019
Q2 2018
Q2 2016
Q3 2014
Q1 2014
Q3 2013
Q2 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro